Abstract:Cystic fibrosis (CF) is caused by different mutations related to the cystic fibrosis transmembrane regulator protein (CFTR), with F508del being the most common. Pioneering the development of CFTR modulators, thanks to the development of effective correctors or potentiators, more recent studies deeply encouraged the administration of triple combination therapeutics. However, combinations of molecules interacting with other proteins involved in functionality of the CFTR channel recently arose as a promising approach to address a large rescue of F508del-CFTR. In this context, the design of compounds properly targeting the molecular chaperone Hsp70, such as the allosteric inhibitor MKT-077, proved to be effective for the development of indirect CFTR modulators, endowed with ability to amplify the accumulation of the rescued protein. Herein we performed structure-based studies of a number of allosteric HSP70 inhibitors, considering the recent X-ray crystallographic structure of the human enzyme. This allowed us to point out the main interaction supporting the binding mode of MKT-077, as well as of the related analogues. In particular, cation-π and π–π stacking with the conserve residue Tyr175 deeply stabilized inhibitor binding at the HSP70 cavity. Molecular docking studies had been followed by QSAR analysis and then by virtual screening of aminoaryl thiazoles (I–IIIa) as putative HSP70 inhibitors. Their effectiveness as CFTR modulators has been verified by biological assays, in combination with VX-809, whose positive results confirmed the reliability of the whole applied computational method. Along with this, the “in-silico” prediction of absorption, distribution, metabolism, and excretion (ADME) properties highlighted, once more, that AATs may represent a chemical class to be further investigated for the rational design of novel combination of compounds for CF treatment.

Small Hsps as Therapeutic Targets of Cystic Fibrosis Transmembrane Conductance Regulator Protein

Chaperoning system: Intriguing target to modulate the expression of CFTR in cystic fibrosis

F508del-CFTR rescue: a matter of cell stress response

Small heat-shock proteins: important players in regulating cellular proteostasis

Structural aspects of the human small heat shock proteins related to their functional activities

The heat shock response and small molecule regulators

Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities

Activation mechanism of Small Heat Shock Protein HSPB5 revealed by disease-associated mutants.

Small heat shock proteins operate as molecular chaperones in the mitochondrial intermembrane space

The Inhibition of the Membrane-Bound Transcription Factor Site-1 Protease (MBTP1) Alleviates the p.Phe508del-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Defects in Cystic Fibrosis Cells

The role and therapeutic potential of Hsp90, Hsp70, and smaller heat shock proteins in peripheral and central neuropathies

Genetic and Pharmacological Modulation of Cellular Proteostasis Leads to Partial Functional Rescue of Homocystinuria-Causing Cystathionine-Beta Synthase Variants

Heat-shock proteins: new keys to the development of cytoprotective therapies

Targeting F508del-CFTR to Develop Rational New Therapies for Cystic Fibrosis

Different anti-aggregation and pro-degradative functions of the members of the mammalian sHSP family in neurological disorders

The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases

Cellular Functions and Mechanisms of Action of Small Heat Shock Proteins

Probing Allosteric Hsp70 Inhibitors by Molecular Modelling Studies to Expedite the Development of Novel Combined F508del CFTR Modulators

Targeting ubiquitination machinery in cystic fibrosis: Where do we stand?

With or without You: Co-Chaperones Mediate Health and Disease by Modifying Chaperone Function and Protein Triage

Therapeutic applications of heat shock proteins and molecular chaperones